The delivery of a next batch of AstraZeneca (CoviShield) Covid-19 vaccine to Ukraine may be postponed for a certain period due to the active information campaign that was launched against the Indian vaccine in our country. It was reported by the chairman of the Verkhovna Rada Committee on Public Health, Medical Assistance and Medical Insurance Mykhailo Radutsky on his Facebook page.
"The Ministry of Foreign Affairs has received a letter from the Indian Embassy, which emphasizes the inadmissibility of defamatory statements about India as a manufacturer of medicines and the AstraZeneca (CoviShield) vaccine supplied to Ukraine," Radutsky wrote.
He noted that the AstraZeneca vaccine (CoviShield) is an absolutely safe and effective drug, which has been confirmed by the World Health Organization. Only in Europe and India, about 50 million doses of this vaccine have already been used. Significant volumes of the drug have been contracted by countries such as Canada, Great Britain, Brazil and others. Ukraine, in turn, has contracted 1.5 million doses of vaccine produced in India.
"According to my information, President Volodymyr Zelensky instructed Ministers Maksym Stepanov and Dmytro Kuleba to find additional ways to speed up the delivery of the next batch of CoviShield vaccine to Ukraine. The Ministry of Health and the Ministry of Foreign Affairs of Ukraine should do everything necessary as soon as possible to convince Indian partners that the state and Ukrainian society are not involved in discrediting the vaccine supplier," Radutsky said.
As we reported earlier, the European Union refined its rules on the export of Covid-19 vaccines, giving it a clearer right to block shipments to countries such as Britain with higher inoculation rates and to those not exporting their own vaccine doses.